SIRS Therapeutics is Drug Discovery in Germany that focus on inflammatory response syndrome business. Founded in 2020. They cover business area such as developer, a drug, acute respiratory distress syndrome, a fibrin-derive peptide, patient, ards, systemic inflammatory response syndrome, SIRS, physician, doctor, acute respiratory disease.
2020
( 4 years old in 2024 )
Inflammatory Response Syndrome
-
Türkenstraße 5
80333 Munich
Germany
Private
developera drugacute respiratory distress syndromea fibrin-derive peptidepatientards, systemic inflammatory response syndromeSIRSphysiciandoctoracute respiratory disease
* We use standard office opening hours in near SIRS Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SIRS Therapeutics is Drug Discovery business from Germany that founded in 2020 (4 years old in 2024), SIRS Therapeutics business is focusing on Inflammatory Response Syndrome.
SIRS Therapeutics headquarter office and corporate office address is located in Türkenstraße 5 80333 Munich Germany.
SIRS Therapeutics was founded in Germany.
In 2024, SIRS Therapeutics is currently focus on inflammatory response syndrome sector.
Above is snippet of Google Trends for "inflammatory response syndrome" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SIRS Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
